Ibsen, Hans

Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol

Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet

Blood Pressure and Hypertension StudiesRenin-Angiotensin System Studies

Cited by 5,407

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet

Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes

Cited by 1,560

Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population

Willum Hansen, T., Staessen, J. A., Torp-Pedersen, C., Rasmussen, S., Thijs, L., Ibsen, H., & Jeppesen, J. (2006) · Circulation

Cardiovascular Health and Disease PreventionCardiovascular Function and Risk Factors

Cited by 1,515

Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study

Boggia, J., Li, Y., Thijs, L., Hansen, T. W., Kikuya, M., Björklund-Bodegård, K., Richart, T., Ohkubo, T., Kuznetsova, T., Torp-Pedersen, C., et al. (2007) · The Lancet

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 887

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol

Wachtell, K., Lehto, M., Gerdts, E., Olsen, M. H., Hornestam, B., Dahlöf, B., Ibsen, H., Julius, S., Kjeldsen, S. E., Lindholm, L. H., et al. (2005) · Journal of the American College of Cardiology

Atrial Fibrillation Management and OutcomesBlood Pressure and Hypertension Studies

Cited by 826

Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study

Ibsen, H., Olsen, M. H., Wachtell, K., Borch-Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlöf, B., Devereux, R. B., de Faire, U., Fyhrquist, F., et al. (2005) · Hypertension

Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes

Cited by 562

Prognostic Value of Reading-to-Reading Blood Pressure Variability Over 24 Hours in 8938 Subjects From 11 Populations

Hansen, T. W., Thijs, L., Li, Y., Boggia, J., Kikuya, M., Björklund-Bodegård, K., Richart, T., Ohkubo, T., Jeppesen, J., Torp-Pedersen, C., et al. (2010) · Hypertension

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 480

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Lindholm, L. H., Ibsen, H., Borch-Johnsen, K., Olsen, M. H., Wachtell, K., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., et al. (2002) · Journal of Hypertension

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 392

Ambulatory Blood Pressure and Mortality: A Population-Based Study

Hansen, T. W., Jeppesen, J., Rasmussen, S., Ibsen, H., & Torp-Pedersen, C. (2005) · Hypertension

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 317

Risk prediction is improved by adding markers of subclinical organ damage to SCORE

Sehestedt, T., Jeppesen, J., Hansen, T. W., Wachtell, K., Ibsen, H., Torp-Petersen, C., Hildebrandt, P., & Olsen, M. H. (2010) · European Heart Journal

Cardiovascular Health and Disease PreventionHealth Promotion and Cardiovascular Prevention

Cited by 315

Diagnostic Thresholds for Ambulatory Blood Pressure Monitoring Based on 10-Year Cardiovascular Risk

Kikuya, M., Hansen, T. W., Thijs, L., Björklund-Bodegård, K., Kuznetsova, T., Ohkubo, T., Richart, T., Torp-Pedersen, C., Lind, L., Ibsen, H., et al. (2007) · Circulation

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 314

Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors.

Clausen, J. O., Borch-Johnsen, K., Ibsen, H., Bergman, R. N., Hougaard, P., Winther, K., & Pedersen, O. (1996) · Journal of Clinical Investigation

Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes

Cited by 259

Masked Hypertension in Diabetes Mellitus: Treatment Implications for Clinical Practice

Franklin, S. S., Thijs, L., Li, Y., Hansen, T. W., Boggia, J., Liu, Y., Asayama, K., Björklund-Bodegård, K., Ohkubo, T., Jeppesen, J., et al. (2013) · Hypertension

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 167

A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD(R) and the Copenhagen Risk Score

Thomsen, T. F., Davidsen, M., Ibsen, H., Jorgensen, T., Jensen, G., & Borch-Johnsen, K. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation

Health Promotion and Cardiovascular PreventionLipoproteins and Cardiovascular Health

Cited by 127